Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 306 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOVIRAX | 200MG | SUSPENSION | Resolved | 2022-05-20 | 2022-08-18 | 161040 |
| ZOVIRAX | 200MG | SUSPENSION | Resolved | 2022-11-11 | 2023-02-15 | 174378 |
| ZOVIRAX | 200MG | SUSPENSION | Actual shortage | 2023-06-23 | 2024-04-01 | 196208 |
| ENGERIX-B | 20MCG | SUSPENSION | Resolved | 2017-04-11 | 2019-12-10 | 6511 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2017-07-06 | 2017-07-11 | 14833 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2017-08-10 | 2018-02-26 | 18724 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2018-03-29 | 2018-11-08 | 44305 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2018-03-29 | 2018-05-02 | 44310 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2018-12-14 | 2020-02-27 | 69619 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2018-12-20 | 2019-01-19 | 70161 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2019-02-22 | 2019-08-03 | 76695 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2020-01-10 | 2020-04-22 | 103046 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2022-10-21 | 2022-11-30 | 172345 |
| HAVRIX 1440 | 1440UNIT | SUSPENSION | Resolved | 2023-11-10 | 2024-02-22 | 209700 |
| MEPRON | 750MG | SUSPENSION | Resolved | 2018-03-05 | 2018-03-29 | 41792 |
| MEPRON | 750MG | SUSPENSION | Resolved | 2021-04-16 | 2021-04-22 | 137630 |
| MEPRON | 750MG | SUSPENSION | Resolved | 2021-07-16 | 2021-07-29 | 142647 |
| MEPRON | 750MG | SUSPENSION | Resolved | 2021-09-08 | 2021-09-11 | 145372 |
| MEPRON | 750MG | SUSPENSION | Resolved | 2022-09-23 | 2022-11-09 | 170088 |
| TWINRIX | 720UNIT 20MCG | SUSPENSION | Resolved | 2017-05-26 | 2017-07-19 | 11383 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
| ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
| ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| PAXIL TAB 10MG | 10MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224405 |
| PAXIL TAB 30MG | 30MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224430 |
| MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |